M. Parvez Alam, Ph.D., of the Drug Discovery Lab, the Easton Center for Alzheimer's Disease Research and the Department of Neurology in the David Geffen School of Medicine at UCLA received the Best Poster Award at the recent Flow Chemistry Congress 2015 held in San Diego, September 15-16.Article: "Green Chemistry" approach wins award at Flow Chemistry Congress.
HCP Live reported Sept. 22 on a study by Dr. Liana Apostolova that found Hippocampus measurements were an effective way to diagnosis early Alzheimer's disease. Apostolova is a Health Sciences Clinical Professor of Neurology at UCLA.
Zee News, Economic Times, The Statesman, NDTV, Sen Times, Advance, and Indo-Asian News Service reported Sept. 17, RTT News, and Bionity.com reported Sept. 18, Hans India reported Sept. 19, and PsychCentral, Sierra Sun Times, and KNBR-TV (San Francisco) reported Sept. 21 on a study by Dr. Dale Bredesen that found that Alzheimer’s disease has three distinct subtypes. Bredesen is a UCLA Visiting Professor of Neurology.
Alzheimer's Disease Study Grabs Attention UCLA Newsroom, Dot.Med, MedicalXpress, and Examiner.com Sept. 16 and Drug Discovery & Development, NewsMax, Bioscience Technology, Financial Express, Laboratory Equipment, Medical News Today, Psychiatry Advisor, Health Canal, Siasat Daily, Web India, Top News, Science Daily, Asian News International, Business Standard, Big News Network, and New Kerala Sept. 17 reported on a study by Dr. Dale Bredesen that found that Alzheimer’s disease has three distinct subtypes. Bredesen is a UCLA Visiting Professor of Neurology.
Newswise, Science Daily, Drug Discovery and Development, Examiner.com, MedicalXpress, News-Medical.net and NewsMax reported July 29 on a study by Dr. Varghese John that found a naturally occurring protein inhibits an enzyme linked to the onset of Alzheimer’s. John is an Associate Adjunct Professor of Neurology and Principle Investigator of the Drug Discovery Lab in the Mary S. Easton Center for Alzheimer's Disease Research at UCLA.